Diagnosis and management of pediatric myocarditis

Paediatric Drugs
Desmond Bohn, Lee Benson

Abstract

Myocarditis is an insidious inflammatory disorder of the myocardium. As a clinical entity, it has been recognized for two centuries, but it defies traditional diagnostic tests. A greater understanding of the immune response underlying the pathobiology of the disorder can lead to a more rational therapeutic approach. The presentation, course and therapeutic options appear to be different in the pediatric compared with the adult population. An understanding of the difference between fulminant and acute progressive myocarditis has led to successful treatment strategies. A variety of new therapies are available, including antiviral agents, immunosuppression, and modulation of the biological response to inflammation. The specific question for patients with myocarditis is whether regimens designed to reduce or eliminate inflammation can provide clinical benefits compared with conventional heart failure therapy. This review highlights pathological mechanisms, modalities of diagnosis, and novel therapies which may improve outcomes.

References

Aug 1, 1975·American Heart Journal·C H LimL P Low
Aug 1, 1992·Journal of the American College of Cardiology·H B WilesJ K Upshur
Feb 1, 1991·Journal of the American College of Cardiology·K Y ChanR M Freedom
Jul 1, 1991·Journal of the American College of Cardiology·R A FriedmanA Garson
Feb 1, 1990·Pediatric Clinics of North America·S W Denfield, A Garson
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T GulickG F Schreiner
Oct 19, 1989·The New England Journal of Medicine·J E ParrilloD Alling
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R KandolfP H Hofschneider
Apr 1, 1986·Journal of the American College of Cardiology·N TomiokaC Kawai
Jan 1, 1988·Pathology and Immunopathology Research·J B O'Connell, J W Mason
Aug 1, 1982·Archives of Disease in Childhood·N Molander
Jul 1, 1995·Journal of the American College of Cardiology·M GroganR J Rodeheffer
Dec 1, 1994·British Heart Journal·A MatsumoriS Sasayama
Feb 23, 1995·The American Journal of Cardiology·T J AndersonP Ganz
Mar 1, 1995·The Annals of Thoracic Surgery·K E WardP C Mantor
Jul 1, 1994·Circulation·A B MartinJ Ni

❮ Previous
Next ❯

Citations

Jun 16, 2010·Artificial Organs·Tilman HumplGlen Van Arsdell
Jun 28, 2011·Pediatrics and Neonatology·Hsiang-Ju HsiaoYu-Sheng Chang
Apr 24, 2010·Current Opinion in Pediatrics·Marla C LevineStephen J Teach
Mar 25, 2006·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Nils ReissReiner Koerfer
Jan 29, 2011·Cardiology in the Young·Lindsay J MayDeborah S Fruitman
Nov 2, 2012·Pediatric Emergency Care·Matthew A EisenbergVincent W Chiang
Feb 1, 2004·Paediatrics & Child Health
May 31, 2019·Hospital Pediatrics·Ashley E WolfJeffrey G Gossett
Sep 28, 2010·Heart Failure Clinics·Uwe Kühl, Heinz-Peter Schultheiss
Dec 7, 2007·Pediatrics·Stephen B FreedmanJennifer Thull-Freedman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.